FDA Approval: TTFields for NSCLC

Podcast | English | 2024 | 37 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

Tumor Treating Fields (TTFields) is a non-invasive cancer treatment that uses alternating electric fields to disrupt the ability of cancer cells to divide. TTFields can slow down tumor growth and may help people live longer than chemotherapy alone. In this episode of Lung Cancer Considered, host Dr. Narjust Florez discusses this new therapy and the Phase III LUNAR study that led to its FDA approval.

Podcast Hosts:

Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, Boston, MA, USA

Podcast Guests:

Ticiana Leal, MD, Director of the Thoracic Medical Oncology Program in the Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA